NEW YORK (GenomeWeb) – Precision Therapeutics announced today that it has signed a definitive agreement to merge with Helomics.

Under the terms of the deal, Precision — formerly Skyline Medical — will acquire the 75 percent of Helmomics' shares it does not currently own, having already taken a 25 percent equity stake in the firm in December.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Customers might want to consider what they might learn about their risk of diseases like Alzheimer's before snagging the genetic testing kits that are on many gift guides this year, NJ.com writes.

The Wall Street Journal reports there is uncertainty surrounding whether He Jiankui's embryo editing did what he said it did.

Stat News reports that the pause on procuring fetal tissue for intramural US National Institutes of Health research will soon affect additional labs there.

In Nature this week: genomic analysis of the invasive fall webworm, amp of constrained coding regions within the human genome, and more.